Prehospital Buprenorphine Treatment for Opioid Use Disorder by Paramedics: First Year Results of the EMS Buprenorphine Use Pilot

References

• Rock P, Singleton M. EMS heroin overdoses with refusal to transport & impacts on ED overdose surveillance. Online J Public Health Inform. 2019;11(1):e430. doi:10.5210/ojphi.v11i1.9917.
   Google Scholar
• Zozula A, Neth MR, Hogan AN, Stolz U, McMullan J. Non-transport after Prehospital Naloxone Administration Is Associated with Higher Risk of Subsequent Non-fatal Overdose. Prehosp Emerg Care. 2022;26(2):272–279. doi: 10.1080/10903127.2021.1884324.
   Google Scholar
• Glenn MJ, Rice AD, Primeau K, Hollen A, Jado I, Hannan P, McDonough S, Arcaris B, Spaite DW, Gaither JB, et al. Refusals after prehospital administration of naloxone during the COVID-19 pandemic. Prehosp Emerg Care. 2021;25(1):46–54. doi:10.1080/10903127.2020.1834656.
   PubMed Web of Science ®Google Scholar
• Hawk KF, D'Onofrio G, Chawarski MC, O'Connor PG, Cowan E, Lyons MS, Richardson L, Rothman RE, Whiteside LK, Owens PH, et al. Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine. JAMA Netw Open. 2020;3(5):e204561. doi:10.1001/jamanetworkopen.2020.4561.
   PubMed Web of Science ®Google Scholar
• Leading causes of death and injury—PDFs|injury center|CDC. Cdc.gov.; 2020 Jul 10 [accessed 2019 Oct 1] https://www.cdc.gov/injury/wisqars/LeadingCauses.html.
   Google Scholar
• Scholl L. Drug and opioid-involved overdose deaths—United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2019;67(5152);1419–1427. doi:10.15585/mmwr.mm6751521e1.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Products—vital statistics rapid release—provision drug overdose data. Centers for Disease Control and Prevention; 2022 Jan 12 [accessed 2020 May 21]. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
   Google Scholar
• Han Y, Yan W, Zheng Y, Khan MZ, Yuan K, Lu L. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Transl Psychiatry. 2019;9(1):282. doi:10.1038/s41398-019-0625-0.
   PubMed Web of Science ®Google Scholar
• Somerville NJ, O'Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, Ruiz S, Babakhanlou-Chase H, Chan M, Callis BP, et al. Characteristics of fentanyl overdose—Massachusetts, 2014-2016. MMWR Morb Mortal Wkly Rep. 2017;66(14):382–6. doi:10.15585/mmwr.mm6614a2.
   PubMed Web of Science ®Google Scholar
• Mars SG, Rosenblum D, Ciccarone D. Illicit fentanyls in the opioid street market: desired or imposed? Addiction. 2019;114(5):774–80. doi:10.1111/add.14474.
   PubMed Web of Science ®Google Scholar
• Weiner SG, Baker O, Bernson D, Schuur JD. One-year mortality of patients after emergency department treatment for nonfatal opioid overdose. Ann Emerg Med. 2020;75(1):13–7. doi:10.1016/j.annemergmed.2019.04.020.
   PubMed Web of Science ®Google Scholar
• Barefoot EH, Cyr JM, Brice JH, Bachman MW, Williams JG, Cabanas JG, Herbert KM. Opportunities for emergency medical services intervention to prevent opioid overdose mortality. Prehosp Emerg Care. 2021;25(2):182–90. doi:10.1080/10903127.2020.1740363.
   PubMed Web of Science ®Google Scholar
• Chua K-P, Dahlem CH, Nguyen TD, Brummet CM, Conti RM, Bohnert AS, Dora-Laskey AD, Kocher KE. Naloxone and buprenorphine prescribing following US emergency department visits for suspected opioid overdose: August 2019 to April. Ann Emerg Med. 2022;79(3):225–236. doi:10.1016/j.annemergmed.2021.10.005.
   PubMedGoogle Scholar
• Carroll GG, Wasserman DD, Shah AA, Salzman MS, Baston KE, Rohrbach RA, Jones IL, Haroz R. Buprenorphine Field Initiation of ReScue Treatment by Emergency Medical Services (Bupe FIRST EMS). A case series. Prehosp Emerg Care. 2020;25:289–293. doi:10.1080/10903127.2020.1747579.
   PubMedGoogle Scholar
• D’Onofrio G, O’Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–44. doi:10.1001/jama.2015.3474.
   PubMed Web of Science ®Google Scholar
• Snyder H, Kalmin MM, Moulin A, Campbell A, Goodman-Meza D, Padwa H, Clayton S, Speener M, Shoptaw S, Herring AA. Rapid adoption of low-threshold buprenorphine treatment at California Emergency Departments participating in the CA Bridge Program. Ann Emerg Med. 2021;78(6):759–772.
   PubMedGoogle Scholar
• Hern HG, Goldstein D, Tzvieli O, Mercer M, Sporer K, Herring AA. Overdose receiving centers—an idea whose time has come? Prehosp Emerg Care. 2021;2:1–4. doi:10.1080/10903127.2020.1864073.
   Google Scholar
• Hern HG, Goldstein D, Kalmin M, Kidane S, Shoptaw S, Tzvieli O, Herring AA. Prehospital initiation of buprenorphine treatment for opioid use disorder by paramedics. Prehosp Emerg Care. 2021;22:1–7. doi:10.1080/10903127.2021.1977440.
   Google Scholar
• Contra Costa County Emergency Medical Services. Suspected opioid overdose; [accessed 2021 Jun 4] 2020. https://cchealth.org/ems/pdf/2021-tg/4A13aSuspectedOpioidOverdose.pdf.
   Google Scholar
• Montalvo C, Stankiewicz B, Brochier A, Henderson DC, Borba CPC. Long-term retention in an outpatient behavioral health clinic with buprenorphine. Am J Addict. 2019;28(5):339–46. doi:10.1111/ajad.12896.
   PubMedGoogle Scholar
• Soares WE, 3rd, Melnick ER, Nath B, D'Onofrio G, Paek H, Skains RM, Walter LA, Casey MF, Napoli A, Hoppe JA, et al. Emergency department visits for nonfatal opioid overdose during the COVID-19 pandemic across six US health care systems. Ann Emerg Med. 2022;79(2):158–67. doi:10.1016/j.annemergmed.2021.03.013.
   PubMed Web of Science ®Google Scholar
• California Department of Public Health. California Overdose Surveillance Dashboard—Contra Costa County, 2021; [accessed 2021 Oct 1]. https://skylab.cdph.ca.gov/ODdash/.
   Google Scholar
• Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622. doi:10.1001/jamanetworkopen.2019.20622.
   PubMed Web of Science ®Google Scholar
• Kalmin MM, Goodman-Meza D, Anderson E, Abid A, Speener M, Snyder H, Campbell A, Moulin A, Shoptaw S, Herring AA. Voting with their feet: social factors linked with treatment for opioid use disorder using same-day buprenorphine delivered in California hospitals. Drug Alcohol Depend. 2021;222:108673. doi:10.1016/j.drugalcdep.2021.108673.
   PubMed Web of Science ®Google Scholar
• Breyre AM, Bains G, Moore J, Siegel L, Sporer KA. Hospice and comfort care patient utilization of emergency medical services. J Palliat Med. 2022;25(2):259–264. doi:10.1089/jpm.2021.0143.
   PubMedGoogle Scholar